Glenda Halliday
#82,067
Most Influential Person Now
Australian neuroscientist
Glenda Halliday's AcademicInfluence.com Rankings
Glenda Hallidaybiology Degrees
Biology
#3583
World Rank
#5458
Historical Rank
Pathology
#34
World Rank
#79
Historical Rank
Neuroscience
#348
World Rank
#364
Historical Rank
Biochemistry
#359
World Rank
#431
Historical Rank
Download Badge
Biology
Why Is Glenda Halliday Influential?
(Suggest an Edit or Addition)According to Wikipedia, Glenda Margaret Halliday is an Australian neuroscientist. As of 2021, she is a professor at the University of Sydney and research fellow in the National Health and Medical Research Council . She was named 2022 NSW Scientist of the Year.
Glenda Halliday's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- MDS clinical diagnostic criteria for Parkinson's disease (2015) (3560)
- Diagnosis and management of dementia with Lewy bodies (2005) (3346)
- Parkinson disease (2017) (1821)
- Diagnosis and management of dementia with Lewy bodies (2017) (1606)
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years (2008) (1575)
- Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration (2007) (1007)
- Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity (1987) (978)
- MDS research criteria for prodromal Parkinson's disease (2015) (897)
- Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies (2019) (871)
- Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update (2009) (869)
- Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. (2013) (866)
- Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria (2009) (711)
- Missing pieces in the Parkinson's disease puzzle (2010) (697)
- Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report (2019) (646)
- Selective neuronal vulnerability in Parkinson disease (2017) (626)
- Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism (2015) (580)
- Clinicopathological correlates in frontotemporal dementia (2004) (556)
- Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. (2002) (545)
- The cerebral cortex is damaged in chronic alcoholics (1997) (510)
- Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy (2017) (502)
- Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions (2010) (475)
- Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations (2008) (398)
- Glia: Initiators and progressors of pathology in Parkinson's disease (2011) (393)
- Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. (1997) (384)
- Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease (2014) (384)
- Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. (2002) (373)
- Degeneration of anterior thalamic nuclei differentiates alcoholics with amnesia. (2000) (372)
- Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease. (2014) (369)
- Survival in frontotemporal dementia (2003) (369)
- Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease (1990) (361)
- A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. (2013) (357)
- Neuropathology underlying clinical variability in patients with synucleinopathies (2011) (352)
- The progression of pathology in longitudinally followed patients with Parkinson’s disease (2008) (348)
- Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease (1990) (343)
- Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy (2015) (340)
- Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr α‐synuclein mutation (2001) (321)
- An inflammatory review of Parkinson’s disease (2002) (317)
- Neuropathologic correlates of white matter hyperintensities (2008) (317)
- Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease (2005) (300)
- A possible role for humoral immunity in the pathogenesis of Parkinson's disease. (2005) (299)
- The neurobiological basis of cognitive impairment in Parkinson's disease (2014) (294)
- Cortical Lewy body pathology in the diagnosis of dementia (2001) (280)
- Regional Specificity of Brain Atrophy in Huntington's Disease (1998) (268)
- Language-associated cortical regions are proportionally larger in the female brain. (1997) (266)
- Frontotemporal dementia and its subtypes: a genome-wide association study (2014) (262)
- The progression of pathology in Parkinson's disease (2010) (261)
- The pathological basis of semantic dementia. (2005) (257)
- The frontotemporal dementia-motor neuron disease continuum (2016) (256)
- Alpha-synuclein biology in Lewy body diseases (2014) (256)
- Staging disease severity in pathologically confirmed cases of frontotemporal dementia (2003) (245)
- Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. (2000) (244)
- PART is part of Alzheimer disease (2015) (243)
- Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: Volume and neuronal number for the output, internal relay, and striatal modulating nuclei (2002) (239)
- FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration (2010) (230)
- α-Synucleinopathy phenotypes. (2014) (225)
- Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene (2000) (223)
- Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease. (2014) (214)
- Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus (1991) (208)
- New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications (2014) (207)
- GSK3B polymorphisms alter transcription and splicing in Parkinson's disease (2005) (204)
- Monocyte Chemoattractant Protein‐1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease (2009) (204)
- Topography of brain atrophy during normal aging and alzheimer's disease (1996) (201)
- Alzheimer’s Disease And Inflammation: A Review Of Cellular And Therapeutic Mechanisms (2000) (197)
- Are Parkinson’s Disease with dementia and Dementia with lewy Bodies the Same Entity? (2004) (197)
- Brain shrinkage in alcoholics: a decade on and what have we learned? (1999) (197)
- Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration–motor neuron disease (2010) (192)
- Copper pathology in vulnerable brain regions in Parkinson's disease (2014) (188)
- Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. (2006) (186)
- Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies (2014) (185)
- Neuronal loss in functional zones of the cerebellum of chronic alcoholics with and without Wernicke's encephalopathy (1999) (185)
- Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation (2002) (180)
- Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans (1996) (180)
- Milestones in Parkinson's disease—Clinical and pathologic features (2011) (177)
- Inflammation is genetically implicated in Parkinson’s disease (2015) (173)
- Degeneration of the centré median–parafascicular complex in Parkinson's disease (2000) (172)
- α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease (2005) (170)
- Eating and hypothalamus changes in behavioral-variant frontotemporal dementia (2011) (168)
- Clinical Significance of Lobar Atrophy in Frontotemporal Dementia: Application of an MRI Visual Rating Scale (2007) (167)
- Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. (2003) (166)
- Chronic alcohol consumption does not cause hippocampal neuron loss in humans (1997) (166)
- Cytoarchitecture of the human dorsal raphe nucleus (1990) (164)
- Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study (2018) (163)
- Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study) (2011) (162)
- Anti-inflammatory drugs protect against Alzheimer disease at low doses. (2000) (162)
- Degeneration in Different Parkinsonian Syndromes Relates to Astrocyte Type and Astrocyte Protein Expression (2009) (161)
- Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology (2016) (160)
- Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. (1991) (159)
- Dementia with Lewy bodies (2004) (158)
- Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations. (2000) (157)
- Pathologically proven frontotemporal dementia presenting with severe amnesia. (2005) (155)
- Validation of the MDS clinical diagnostic criteria for Parkinson's disease (2018) (153)
- Comparative anatomy of the ventromedial mesencephalic tegmentum in the rat, cat, monkey and human (1986) (151)
- Lipid Pathway Alterations in Parkinson's Disease Primary Visual Cortex (2011) (151)
- Alpha synuclein in Parkinson's disease (2014) (150)
- The comparative biology of neuromelanin and lipofuscin in the human brain (2008) (147)
- Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks? (2011) (147)
- Focal demyelination in Alzheimer’s disease and transgenic mouse models (2010) (146)
- c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease. (2014) (146)
- p25α Relocalizes in Oligodendroglia from Myelin to Cytoplasmic Inclusions in Multiple System Atrophy (2007) (145)
- A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse (2012) (145)
- Reduced T helper and B lymphocytes in Parkinson's disease (2012) (143)
- In vivo and post-mortem memory circuit integrity in frontotemporal dementia and Alzheimer's disease. (2012) (142)
- Parkinson disease-associated cognitive impairment (2021) (141)
- Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. (2005) (139)
- Loss of vasopressin-immunoreactive neurons in alcoholics is dose-related and time-dependent (1996) (139)
- Parkinson's Disease Is Not Simply a Prion Disorder (2017) (139)
- Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease (2006) (137)
- Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. (2001) (137)
- Thalamic changes in Parkinson's disease. (2009) (136)
- T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas. (1997) (135)
- Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss (2002) (133)
- Atlas of the developing mouse brain at E 17.5, P0, and P6 (2007) (132)
- Gut–brain axis and the spread of α‐synuclein pathology: Vagal highway or dead end? (2019) (132)
- Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders (2019) (130)
- Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study (2019) (128)
- Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing (2019) (127)
- Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. (2003) (126)
- Biomarkers in dementia: clinical utility and new directions (2014) (126)
- Specific A10 Dopaminergic Nuclei in the Midbrain Degenerate in Parkinson's Disease (1997) (125)
- Broad-spectrum sunscreens provide greater protection against ultraviolet-radiation-induced suppression of contact hypersensitivity to a recall antigen in humans. (1997) (125)
- Variations in the neuropathology of familial Alzheimer’s disease (2009) (124)
- Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts (2019) (123)
- Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. (2002) (122)
- Pyramidal Cell Loss in Motor Cortices in Huntington's Disease (2002) (120)
- TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions (2014) (119)
- Tricks of the mind: Visual hallucinations as disorders of attention (2014) (114)
- Neuroinflammation in frontotemporal dementia (2019) (113)
- Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism (2016) (113)
- Selective cell death in neurodegeneration: Why are some neurons spared in vulnerable regions? (2010) (113)
- Distribution of monoamine‐synthesizing neurons in the human medulla oblongata (1988) (113)
- Genetic contributions to Parkinson's disease (2004) (111)
- Variation in hippocampal neuron number with age and brain volume. (1998) (111)
- Localization of copper and copper transporters in the human brain. (2013) (110)
- C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts (2012) (110)
- TDP-43 proteinopathies: a new wave of neurodegenerative diseases (2020) (110)
- Molecular Pathogenesis of the Tauopathies. (2019) (108)
- Lysosomal‐associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease (2015) (107)
- Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson’s disease (2011) (106)
- The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part II (2007) (106)
- Regional brain atrophy in progressive supranuclear palsy and Lewy body disease (2000) (106)
- Inhibitor treatment of peripheral mononuclear cells from Parkinson’s disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarker (2016) (106)
- Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson's disease. (2006) (105)
- Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies (2017) (105)
- Selective loss of pyramidal neurons in the pre‐supplementary motor cortex in Parkinson's disease (2002) (105)
- A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease. (2005) (104)
- pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium (2009) (103)
- Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies (2004) (102)
- The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease (2014) (102)
- Mutations in progranulin explain atypical phenotypes with variants in MAPT. (2006) (102)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture (2021) (99)
- An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies (2006) (99)
- Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology (2015) (99)
- p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. (2007) (98)
- Neuronal network disintegration: common pathways linking neurodegenerative diseases (2016) (98)
- Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses (2010) (98)
- Pedigree with frontotemporal lobar degeneration – motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9 (2008) (97)
- Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. (2011) (97)
- Multiple Biological Pathways Link Cognitive Lifestyle to Protection from Dementia (2012) (96)
- Movement disorder society criteria for clinically established early Parkinson's disease (2018) (96)
- Low-dose UVA and UVB have different time courses for suppression of contact hypersensitivity to a recall antigen in humans. (1999) (95)
- Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease (2014) (94)
- Neuropathology of α‐synuclein propagation and braak hypothesis (2016) (94)
- Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. (2004) (93)
- Cerebellar atrophy in Parkinson's disease and its implication for network connectivity. (2016) (93)
- Practical considerations for the use of the optical disector in estimating neuronal number (1994) (91)
- Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease (1996) (90)
- Specific temporoparietal gyral atrophy reflects the pattern of language dissolution in Alzheimer's disease. (1999) (90)
- Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects (2012) (88)
- Cytoarchitecture of serotonin‐synthesizing neurons in the pontine tegmentum of the human brain (1991) (87)
- Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease (2016) (86)
- Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson's disease. (1991) (85)
- No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism (2009) (85)
- Clinicopathological Staging of Frontotemporal Dementia Severity: Correlation with Regional Atrophy (2004) (84)
- Cerebellar Integrity in the Amyotrophic Lateral Sclerosis - Frontotemporal Dementia Continuum (2014) (84)
- The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy (2022) (84)
- Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. (2005) (84)
- Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study (2018) (83)
- TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes. (2015) (83)
- Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders. (2003) (82)
- GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area (2012) (82)
- LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models (2012) (81)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. (2018) (81)
- Distribution of brain atrophy in behavioral variant frontotemporal dementia (2005) (80)
- Longitudinal white matter changes in frontotemporal dementia subtypes (2014) (80)
- An Improved High-Throughput Lipid Extraction Method for the Analysis of Human Brain Lipids (2013) (79)
- Regional brain atrophy in idiopathic parkinson's disease and diffuse Lewy body disease. (1996) (79)
- Striatal β-amyloid in dementia with Lewy bodies but not Parkinson’s disease (2011) (77)
- Aβ and tau prion-like activities decline with longevity in the Alzheimer’s disease human brain (2019) (77)
- Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain. (2017) (76)
- Brainstem Serotonergic Neurons in Chronic Alcoholics With and Without the Memory Impairment of Korsakoff's Psychosis (1993) (76)
- Postmortem analysis of bilateral subthalamic electrode implants in Parkinson's disease (2002) (76)
- The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part I (2007) (75)
- DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E In Vitro (2014) (75)
- Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases (2016) (74)
- The new definition and diagnostic criteria of Parkinson's disease (2016) (74)
- Localization of immunoreactivity for Deleted in Colorectal Cancer (DCC), the receptor for the guidance factor netrin-1, in ventral tier dopamine projection pathways in adult rodents (2005) (74)
- Quantification of cortical atrophy in a case of progressive fluent aphasia. (1996) (73)
- Systems-Based Analyses of Brain Regions Functionally Impacted in Parkinson's Disease Reveals Underlying Causal Mechanisms (2014) (72)
- Immunohistochemical evidence for macroautophagy in neurones and endothelial cells in Alzheimer's disease (2010) (72)
- Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation (2004) (71)
- Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesis (2014) (71)
- Idiopathic generalized epilepsy (2000) (71)
- Pathology and hippocampal atrophy in Alzheimer's disease (2017) (70)
- Identifying severely atrophic cortical subregions in Alzheimer’s disease (2003) (70)
- Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient (2016) (70)
- β‐Amyloid treatment of two complementary P301L tau‐expressing Alzheimer's disease models reveals similar deregulated cellular processes (2006) (70)
- Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson’s disease brain (2017) (69)
- White matter loss in healthy ageing: A postmortem analysis (2009) (69)
- Effect of anti-inflammatory medications on neuropathological findings in Alzheimer disease. (2000) (69)
- The Subthalamic Nucleus in Parkinson's Disease and Progressive Supranuclear Palsy (1997) (69)
- ALS/FTLD: experimental models and reality (2017) (68)
- Abnormal connectivity between the default mode and the visual system underlies the manifestation of visual hallucinations in Parkinson’s disease: a task-based fMRI study (2015) (68)
- Alpha‐synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation (2018) (68)
- C-abl Phosphorylates Alpha-synuclein And Regulates Its Degradation, Implication For Alpha-synuclein Clearance And Contribution To The Pathogenesis Of Parkinson's Disease (2014) (68)
- Relationship between hippocampal volume and CA1 neuron loss in brains of humans with and without Alzheimer's disease (2004) (68)
- Anti-melanin antibodies are increased in sera in Parkinson's disease (2009) (67)
- Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease (2017) (67)
- Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease (2018) (67)
- Aβ-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease (2015) (66)
- Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies. (2000) (66)
- MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer’s disease (2016) (66)
- The left human speech-processing cortex is thinner but longer than the right (2003) (66)
- Characterization of circular RNAs landscape in multiple system atrophy brain (2016) (66)
- MSA prions exhibit remarkable stability and resistance to inactivation (2017) (66)
- Neurofibrillary degeneration and cell loss in the nucleus basalis in comparison to cortical Alzheimer pathology (1998) (64)
- Ultraviolet radiation induced suppression of Mantoux reactions in humans. (1998) (64)
- Increased peripheral inflammation in asymptomatic leucine‐rich repeat kinase 2 mutation carriers (2016) (64)
- Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson's disease. (2019) (64)
- FTD and ALS—translating mouse studies into clinical trials (2015) (64)
- Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat (2003) (63)
- Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD (2019) (63)
- Visual hallucinations in Parkinson's disease: Theoretical models (2014) (62)
- Physiological changes in neurodegeneration — mechanistic insights and clinical utility (2018) (62)
- Distribution of substance P‐like immunoreactive neurons in the human medulla oblongata: Co‐localization with monoamine‐synthesizing neurons (1988) (62)
- Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease? (2012) (62)
- LRRK2‐mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients (2018) (61)
- Significant loss of pyramidal neurons in the angular gyrus of patients with Huntington's disease (1997) (61)
- Dolichol is the major lipid component of human substantia nigra neuromelanin (2005) (61)
- Substantia nigra echomorphology in the healthy very old: Correlation with motor slowing (2007) (61)
- Motor cortical function determines prognosis in sporadic ALS (2016) (61)
- CHAPTER 34 – The Serotonin and Tachykinin Systems (2004) (61)
- Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy (2014) (61)
- Diffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer's disease. (1996) (60)
- Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways (2015) (59)
- Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease (1997) (59)
- Low serum progranulin predicts the presence of mutations: a prospective study. (2010) (59)
- Substantia nigra pars reticulata neurons in Parkinson's disease. (1996) (59)
- Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS (2015) (59)
- A critique of the second consensus criteria for multiple system atrophy (2019) (59)
- Two novel presenilin‐1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's disease (1998) (57)
- Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease (2019) (57)
- Parkinson’s progression prediction using machine learning and serum cytokines (2019) (57)
- Sunscreens protect epidermal Langerhans cells and Thy-1+ cells but not local contact sensitization from the effects of ultraviolet light. (1992) (57)
- Progressive Supranuclear Palsy Affects both the Substantia Nigra Pars Compacta and Reticulata (1997) (57)
- Selective hippocampal neuron loss in dementia with Lewy bodies (2002) (56)
- Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria (2002) (56)
- Neuropathologic assessment of participants in two multi‐center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN) (2015) (56)
- Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease (2016) (56)
- ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies (2013) (56)
- Isoform-specific proteolysis of apolipoprotein-E in the brain (2011) (55)
- Small‐vessel disease in patients with Parkinson's disease: A clinicopathological study (2012) (55)
- Practical measures to simplify the Braak tangle staging method for routine pathological screening (2000) (55)
- Can we clinically diagnose dementia with Lewy bodies yet? (2013) (54)
- ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain. (2016) (54)
- Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human (1995) (54)
- Autophagy activation promotes clearance of α-synuclein inclusions in fibril-seeded human neural cells (2019) (53)
- Presenilin-1 Mutation L271V Results in Altered Exon 8 Splicing and Alzheimer's Disease with Non-cored Plaques and No Neuritic Dystrophy* (2003) (53)
- Pick bodies in a family with presenilin‐1 Alzheimer's disease (2005) (53)
- The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion (2016) (53)
- Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines (2019) (53)
- Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease? (2009) (52)
- Intralaminar nuclei of the thalamus in Lewy body diseases (2009) (52)
- Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study (2021) (52)
- Protective properties of lysozyme on β-amyloid pathology: implications for Alzheimer disease (2015) (52)
- The distribution of neuropeptide Y-like immunoreactive neurons in the human medulla oblongata (1988) (52)
- CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis. (2020) (52)
- Glial fibrillary acidic protein (GFAP) immunohistochemistry in human cortex: a quantitative study using different antisera (1996) (51)
- Quantitation and three‐dimensional reconstruction of Ch4 nucleus in the human basal forebrain (1993) (51)
- The neural basis of semantic memory: Evidence from semantic dementia (2009) (51)
- Analysis of DNA methylation associates the cystine–glutamate antiporter SLC7A11 with risk of Parkinson’s disease (2020) (50)
- Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43 (2013) (50)
- Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies (2004) (50)
- Corticobasal syndrome with tau pathology (2001) (50)
- Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies (2001) (50)
- Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival (2016) (50)
- A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation. (2004) (50)
- A comparative analysis of neurons containing catecholamine-synthesizing enzymes and neuropeptide Y in the ventrolateral medulla of rats, guinea-pigs and cats (1991) (49)
- Systemic metabolism in frontotemporal dementia (2014) (49)
- Calbindin D28k-containing neurons are restricted to the medial substantia nigra in humans (1995) (48)
- Eating behavior in frontotemporal dementia (2015) (48)
- Beyond the temporal pole: limbic memory circuit in the semantic variant of primary progressive aphasia. (2014) (48)
- Influence of Single Nucleotide Polymorphisms in COMT, MAO-A and BDNF Genes on Dyskinesias and Levodopa Use in Parkinson's Disease (2013) (48)
- Neurof ibrillary tangles in chronic alcoholics (1995) (48)
- A role for the substantia nigra pars reticulata in the gaze palsy of progressive supranuclear palsy. (2000) (47)
- Distribution of pathology in frontal variant Alzheimer's disease. (2014) (46)
- Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition. (2017) (46)
- Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimer's disease. (2011) (46)
- Serotonin-like immunoreactive cells and fibres in the rat ventromedial mesencephalic tegmentum (1989) (46)
- Evidence for specific phases in the development of human neuromelanin (2006) (46)
- Anterior cingulate integrity: Executive and neuropsychiatric features in Parkinson's disease (2012) (46)
- Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson's disease (2006) (46)
- Distinctive pathological mechanisms involved in primary progressive aphasias (2016) (46)
- The nucleus basalis (Ch4) in the alcoholic Wernicke-Korsakoff syndrome: reduced cell number in both amnesic and non-amnesic patients (1997) (46)
- Measurement of LRRK2 and Ser910/935 phosphorylated LRRK2 in peripheral blood mononuclear cells from idiopathic Parkinson's disease patients. (2013) (46)
- Lipid dysfunction and pathogenesis of multiple system atrophy (2014) (45)
- Tyrosine hydroxylase-containing neurons in the supraoptic and paraventricular nuclei of the adult human (1988) (45)
- Lesion of thalamic centromedian– parafascicular complex after chronic deep brain stimulation (2001) (45)
- Neurofilament-Immunoreactive Neurons in Alzheimer's Disease and Dementia with Lewy Bodies (2002) (45)
- Abolishing the 1‐year rule: How much evidence will be enough? (2016) (45)
- The locus coeruleus and memory: a study of chronic alcoholics with and without the memory impairment of Korsakoff's psychosis (1992) (45)
- The substantia nigra and ventral tegmental dopaminergic neurons from development to degeneration (2016) (44)
- Psychiatric disorders in C9orf72 kindreds (2018) (44)
- Glucocerebrosidase deficits in sporadic Parkinson disease (2014) (43)
- Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands (2017) (42)
- Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy (2011) (42)
- Increased ATP-binding cassette transporter A1 expression in Alzheimer's disease hippocampal neurons. (2010) (42)
- Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain (2017) (42)
- Human-based studies on α-synuclein deposition and relationship to Parkinson's disease symptoms (2008) (42)
- Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework. (2019) (42)
- Variable phenotype of Alzheimer’s disease with spastic paraparesis (2007) (42)
- Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease (2013) (41)
- The Internal Globus Pallidus Is Affected in Progressive Supranuclear Palsy and Parkinson's Disease (1999) (41)
- An emerging role for LRRK2 in the immune system. (2012) (41)
- Early‐onset axonal pathology in a novel P301S‐Tau transgenic mouse model of frontotemporal lobar degeneration (2015) (41)
- Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease (2021) (40)
- Progression in Behavioral Variant Frontotemporal Dementia: A Longitudinal Study. (2015) (40)
- Unique Transcriptome Patterns of the White and Grey Matter Corroborate Structural and Functional Heterogeneity in the Human Frontal Lobe (2013) (40)
- Decline in Proliferation and Immature Neuron Markers in the Human Subependymal Zone during Aging: Relationship to EGF- and FGF-Related Transcripts (2016) (40)
- Differences in regional brain atrophy in genetic forms of Alzheimer's disease (2006) (40)
- Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes (2017) (40)
- Clinical phenotypes in autopsy-confirmed Pick disease (2011) (39)
- Cellular and regional vulnerability in frontotemporal tauopathies (2019) (39)
- Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's Disease (2007) (39)
- Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone. (2019) (38)
- Substance P-containing neurons in the pontomesencephalic tegmentum of the human brain (1990) (38)
- Dopamine Depletion Alters Macroscopic Network Dynamics in Parkinson’s Disease (2018) (38)
- Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP‐17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer’s disease (2006) (38)
- Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques (2004) (38)
- LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions (2008) (38)
- What is the dominant aβ species in human brain tissue? A review (2009) (37)
- Rostrocaudal differences in morphology and neurotransmitter content of cells in the subretrofacial vasomotor nucleus. (1992) (36)
- Exploring Myelin Dysfunction in Multiple System Atrophy (2014) (36)
- Cortical degeneration associated with phonologic and semantic language impairments in AD (2001) (36)
- The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy (1999) (36)
- Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers (2017) (35)
- Parkin Co-regulated Gene (PACRG) is regulated by the ubiquitin–proteasomal system and is present in the pathological features of parkinsonian diseases (2007) (35)
- ABCA5 regulates amyloid-β peptide production and is associated with Alzheimer's disease neuropathology. (2014) (35)
- New face of neuromelanin. (2006) (35)
- Uncovering pathophysiological changes in frontotemporal dementia using serum lipids (2020) (35)
- Evidence for specific phases in the development of human neuromelanin (2006) (35)
- Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer's disease. (2010) (35)
- Substantia Nigra and Locus Coeruleus (2004) (34)
- Phosphorylation of soluble tau differs in Pick’s disease and Alzheimer’s disease brains (2009) (34)
- Circular RNAs: The Brain Transcriptome Comes Full Circle (2020) (34)
- Neuropathological correlates of memory dysfunction in the Wernicke-Korsakoff syndrome. (1994) (33)
- LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies (2017) (33)
- Srp20 regulates TrkB pre‐mRNA splicing to generate TrkB‐Shc transcripts with implications for Alzheimer’s disease (2012) (33)
- Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia. (2017) (33)
- Transcriptome analysis of grey and white matter cortical tissue in multiple system atrophy (2015) (33)
- Amyloid beta selectively modulates neuronal TrkB alternative transcript expression with implications for Alzheimer's disease (2012) (33)
- Intraneuronal advanced glycation endproducts in presenilin‐1 Alzheimer's disease (2002) (33)
- ABCA8 stimulates sphingomyelin production in oligodendrocytes. (2013) (32)
- Preliminary Evidence Suggesting Delayed Development in the Hypoglossal and Vagal Nuclei of SIDS Infants: A Necropsy Study (1992) (32)
- Lipidomics Analysis of Behavioral Variant Frontotemporal Dementia: A Scope for Biomarker Development (2018) (32)
- Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG) (2017) (32)
- Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease. (2016) (32)
- Substantia Nigra, Ventral Tegmental Area, and Retrorubral Fields (2012) (32)
- SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease (2018) (32)
- Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia (2019) (32)
- Genetically confirmed clinical Huntington’s disease with no observable cell loss (2003) (31)
- Staging disease severity in movement disorder tauopathies: Brain atrophy separates progressive supranuclear palsy from corticobasal degeneration (2005) (31)
- The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration (2003) (31)
- Parkinson’s Disease Subtypes: Critical Appraisal and Recommendations (2021) (31)
- Serotonergic markers in Parkinson's disease and levodopa‐induced dyskinesias (2015) (31)
- FAS-Dependent Cell Death in α-Synuclein Transgenic Oligodendrocyte Models of Multiple System Atrophy (2013) (31)
- Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro. (2005) (31)
- A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein (2016) (31)
- Olfactory deficits and sleep disturbances in Parkinson’s disease: a case–control survey (2003) (31)
- A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers (2018) (30)
- Chronic alcoholics without Wernicke-Korsakoff syndrome or cirrhosis do not lose serotonergic neurons in the dorsal raphe nucleus. (1996) (30)
- A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers (2018) (30)
- Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells (2005) (30)
- von Economo Neuron Density and Thalamus Volumes in Behavioral Deficits in Frontotemporal Dementia Cases with and without a C9ORF72 Repeat Expansion. (2017) (30)
- Similar early clinical presentations in familial and non-familial frontotemporal dementia (2004) (30)
- DNA extraction from fresh-frozen and formalin-fixed, paraffinembedded human brain tissue (2013) (30)
- Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD) (2015) (29)
- Effect of chronic alcohol consumption on the human locus coeruleus. (1994) (29)
- High expression of long intervening non-coding RNA OLMALINC in the human cortical white matter is associated with regulation of oligodendrocyte maturation (2015) (29)
- Utility and Limitations of Addenbrooke’s Cognitive Examination-Revised for Detecting Mild Cognitive Impairment in Parkinson’s Disease (2011) (29)
- Chronic alcoholics have substantial glial pathology in the forebrain and diencephalon. (1994) (29)
- Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: a case study (2015) (29)
- Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2017) (29)
- Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions (2015) (29)
- Neuronal intranuclear inclusion disease is genetically heterogeneous (2020) (29)
- α-Synuclein Regulates Neuronal Cholesterol Efflux (2017) (29)
- Subtle gait and balance impairments occur in idiopathic rapid eye movement sleep behavior disorder (2019) (28)
- Alzheimer's disease: its diagnosis and pathogenesis. (2001) (28)
- Heritability in frontotemporal dementia: more missing pieces? (2014) (28)
- Hemorrhage is uncommon in new Alzheimer family with Flemish amyloid precursor protein mutation (2004) (28)
- Accelerated aging exacerbates a pre‐existing pathology in a tau transgenic mouse model (2017) (28)
- Chronic traumatic encephalopathy in two former Australian National Rugby League players (2019) (28)
- Serotonin and alcohol-related brain damage (1995) (27)
- Cognitive, Extrapyramidal, and Magnetic Resonance Imaging Predictors of Functional Impairment in Nondemented Older Community Dwellers: The Sydney Older Person Study (2006) (27)
- Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms. (2008) (27)
- Pathological Staging of Frontotemporal Lobar Degeneration (2011) (27)
- CHAPTER 10 – Organization of Human Brain Stem Nuclei (2004) (27)
- Postmortem analysis of bilateral subthalamic electrode implants in Parkinson's disease. (2002) (27)
- Topical and oral retinoids protect Langerhans' cells and epidermal Thy-1+ dendritic cells from being depleted by ultraviolet radiation. (1991) (27)
- The case of a 48 year-old woman with bizarre and complex delusions (2010) (27)
- Antigen-epitope retrieval to facilitate proteomic analysis of formalin-fixed archival brain tissue. (2006) (26)
- Ubiquitin‐positive inclusions and progression of pathology in frontotemporal dementia and motor neurone disease identifies a group with mainly early pathology (2006) (26)
- Excessive dopamine neuron loss in progressive supranuclear palsy (2008) (26)
- Increased Ndfip1 in the Substantia Nigra of Parkinsonian Brains Is Associated with Elevated Iron Levels (2014) (26)
- Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis (2017) (26)
- Retrosplenial Cortex (BA 29) Volumes in Behavioral Variant Frontotemporal Dementia and Alzheimer’s Disease (2013) (26)
- Severe Anterograde Amnesia with Extensive Hippocampal Degeneration in a Case of Rapidly Progressive Frontotemporal Dementia. (2001) (26)
- Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies (2020) (25)
- Is seladin-1 really a selective Alzheimer's disease indicator? (2012) (25)
- Heritability and genetic variance of dementia with Lewy bodies (2018) (25)
- Expanding the phenotypic associations of globular glial tau subtypes (2016) (25)
- Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing (2021) (24)
- Validation of the Psychosis and Hallucinations Questionnaire in Non‐demented Patients with Parkinson's Disease (2015) (24)
- The pathogenesis of cingulate atrophy in behavioral variant frontotemporal dementia and Alzheimer’s disease (2013) (24)
- Re-evaluating the glio-centric view of multiple system atrophy by highlighting the neuronal involvement. (2015) (24)
- Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation (2012) (24)
- VISA--a pass to innate immunity. (2007) (24)
- Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer’s disease (2008) (24)
- Four groups of tyrosine hydroxylase-immunoreactive neurons in the ventrolateral medulla of rats, guinea-pigs and cats identified on the basis of chemistry, topography and morphology (1991) (24)
- Region- and Cell-specific Aneuploidy in Brain Aging and Neurodegeneration (2018) (23)
- Aspects of Innate Immunity and Parkinson’s Disease (2012) (23)
- Strand-specific RNA-sequencing analysis of multiple system atrophy brain transcriptome (2016) (23)
- Novel ‘inflammatory plaque’ pathology in presenilin‐1 Alzheimer's disease (2005) (23)
- Mitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian community (2009) (23)
- Frontotemporal dementia–amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1–q12.2: genetic, clinical and neuropathological analysis (2013) (23)
- Aneuploidy in Lewy body diseases (2015) (23)
- Effect of age on proliferation‐regulating factors in human adult neurogenic regions (2010) (23)
- Reproducible sampling regimen for specific cortical regions: application to speech-associated areas (1996) (22)
- Apolipoprotein-E forms dimers in human frontal cortex and hippocampus (2010) (22)
- P25α immunoreactive but α-synuclein immunonegative neuronal inclusions in multiple system atrophy (2006) (22)
- Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders (2021) (22)
- Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting (2018) (22)
- Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra (2013) (22)
- Changes in sphingomyelin level affect alpha-synuclein and ABCA5 expression. (2012) (22)
- Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis? (2015) (22)
- Impulsivity, decreased social exploration, and executive dysfunction in a mouse model of frontotemporal dementia (2016) (22)
- Apolipoprotein D Upregulation in Alzheimer’s Disease but Not Frontotemporal Dementia (2018) (22)
- Terra incognita—cerebellar contributions to neuropsychiatric and cognitive dysfunction in behavioral variant frontotemporal dementia (2015) (22)
- Pallidal stimulation reduces treatment‐induced dyskinesias in “minimal‐change” multiple system atrophy (2005) (22)
- Further evidence for an association between a mutation in the APP gene and Lewy body formation (1997) (22)
- Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis (2021) (21)
- Predictors of survival and progression in behavioural variant frontotemporal dementia (2019) (21)
- Clinical features of Lewy body dementia: insights into diagnosis and pathophysiology (2019) (21)
- Proceedings of the Australian Neuroscience Society Symposium: Schizophrenia A REVIEW OF THE NEUROPATHOLOGY OF SCHIZOPHRENIA (2001) (21)
- The dorsal, posterodorsal, and ventral tegmental nuclei: A cyto‐ and chemoarchitectonic study in the human (1992) (21)
- The relationships between mild cognitive impairment and phenotype in Parkinson’s disease (2015) (21)
- ROCK1 Is Associated with Alzheimer’s Disease-Specific Plaques, as well as Enhances Autophagosome Formation But not Autophagic Aβ Clearance (2016) (21)
- Increased expression of ABCA8 in multiple system atrophy brain is associated with changes in pathogenic proteins. (2013) (20)
- Mechanisms of cell death in cholinergic basal forebrain neurons in chronic alcoholics (1995) (20)
- PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease (2021) (20)
- Long intervening non-coding RNA 00320 is human brain-specific and highly expressed in the cortical white matter (2015) (20)
- Improved selectivity and sensitivity in the visualization of neurofibrillary tangles, plaques and neuropil threads. (1996) (20)
- Clinical correlates of similar pathologies in parkinsonian syndromes (2011) (20)
- Application of antiphenylalanine hydroxylase antibodies to the study of the serotonergic system in the human brain (1992) (19)
- Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation (2020) (19)
- Mouse models of frontotemporal dementia: A comparison of phenotypes with clinical symptomatology (2017) (19)
- Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia. (2017) (19)
- Heritability in frontotemporal tauopathies (2019) (19)
- Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer's disease (2009) (18)
- The midbrain dopaminergic cell groups in the baboon papio ursinus (1998) (18)
- Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease (2016) (18)
- Accumulation of dysfunctional SOD1 protein in Parkinson’s disease is not associated with mutations in the SOD1 gene (2017) (18)
- Fatty acid composition of the anterior cingulate cortex indicates a high susceptibility to lipid peroxidation in Parkinson's disease. (2015) (18)
- Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology (2021) (18)
- Levels of glial cell line‐derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson’s disease (2019) (18)
- SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians (2015) (18)
- A comparative study of avidin-biotin-peroxidase complexes for the immunohistochemical detection of antigens in neural tissue. (1992) (18)
- CD4+ T lymphocyte infiltration correlates with regression of a UV-induced squamous cell carcinoma. (1995) (18)
- The relationship between clinical and pathological variables in Richardson’s syndrome (2012) (18)
- Transcriptional profiling of multiple system atrophy cerebellar tissue highlights differences between the parkinsonian and cerebellar sub-types of the disease (2020) (17)
- Dementia in long-term Parkinson’s disease patients: a multicentre retrospective study (2020) (17)
- DAT‐SPECT diagnoses dopamine depletion, but not PD (2014) (17)
- Neuropathology in the S305S tau gene mutation. (2006) (17)
- Clinical and Neuropathological Abnormalities in Baboons Treated with HPTP, the Tetrahydropyridine Analog of Haloperidol (1999) (17)
- Cross-examining candidate genes implicated in multiple system atrophy (2019) (17)
- Improved prediction of chronological age from DNA methylation limits it as a biomarker of ageing (2018) (17)
- Elevation in Sphingomyelin Synthase Activity Is Associated with Increases in Amyloid-Beta Peptide Generation (2013) (17)
- Animal modeling an oligodendrogliopathy – multiple system atrophy (2016) (17)
- Comparison of Locus Coeruleus Pathology with Nigral and Forebrain Pathology in Parkinson's Disease (2021) (17)
- Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson’s disease (2018) (16)
- TDP-43 levels in the brain tissue of ALS cases with and without C9ORF72 or ATXN2 gene expansions (2019) (16)
- A comprehensive screening of copy number variability in dementia with Lewy bodies (2019) (16)
- Tenuigenin Attenuates α‐Synuclein‐Induced Cytotoxicity by Down‐Regulating Polo‐Like Kinase 3 (2013) (16)
- Keratoacanthomas have an immunosuppressive cytokine environment of increased IL-10 and decreased GM-CSF compared to squamous cell carcinomas (1999) (16)
- Assessing the role of nocturnal core body temperature dysregulation as a biomarker of neurodegeneration (2019) (16)
- Haplotype analysis of the IGF2‐INS‐TH gene cluster in Parkinson's disease (2008) (16)
- What is the dominant Abeta species in human brain tissue? A review. (2005) (15)
- A 6-Year Study of Cognition and Spatial Function in the Demented and Non-Demented Elderly: The Sydney Older Persons Study (2003) (15)
- A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson's disease (2007) (15)
- Parkinson's disease with late Pick's dementia (2001) (15)
- The underacknowledged PPA-ALS (2019) (15)
- Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration (2019) (15)
- Identification of families with cortical Lewy body disease (2004) (15)
- Altered High Density Lipoprotein Composition in Behavioral Variant Frontotemporal Dementia (2018) (15)
- Alpha-synuclein: prion or prion-like? (2019) (15)
- Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice (2018) (15)
- Intracellular and secreted forms of clusterin are elevated early in Alzheimer's disease and associate with both Aβ and tau pathology (2019) (15)
- Mutations in protein N-arginine methyltransferases are not the cause of FTLD-FUS (2013) (14)
- Leucine‐rich repeat kinase 2 and alternative splicing in Parkinson's disease (2012) (14)
- Relationship between neuronal loss and ‘inflammatory plaques’ in early onset Alzheimer's disease (2007) (14)
- Increased Tau Phosphorylation in Motor Neurons From Clinically Pure Sporadic Amyotrophic Lateral Sclerosis Patients. (2019) (14)
- Topical retinoic acid augments ultraviolet light‐induced melanogenesis (1992) (14)
- Multiple system atrophy (2022) (14)
- Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer’s disease and not in other tauopathies (2019) (14)
- Ubiquitin-positive achromatic neurons in corticobasal degeneration (2004) (14)
- Targeted, High-resolution RNA Sequencing of Non-coding Genomic Regions Associated with Neuropsychiatric Functions (2019) (14)
- Brain stem nuclei in sudden infant death syndrome (SIDS): volumes, neuronal numbers and positions (1995) (14)
- Pathway Analysis of the Human Brain Transcriptome in Disease (2013) (13)
- Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord (2022) (13)
- Multiple neuronal pathologies are common in young patients with pathologically proven Frontotemporal lobar degeneration (2018) (13)
- Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies (2017) (13)
- The C9orf72 hexanucleotide repeat expansion presents a challenge for testing laboratories and genetic counseling (2019) (13)
- Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates (2020) (13)
- Tryptophan is a marker of human postmortem brain tissue quality (2009) (13)
- Neurotransmitter Changes in Alzheimer’s Disease (1995) (13)
- Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease (2019) (13)
- Reduced adult neurogenesis is associated with increased macrophages in the subependymal zone in schizophrenia (2021) (13)
- Targeted, High-Resolution RNA Sequencing of Non-coding Genomic Regions Associated With Neuropsychiatric Functions (2019) (13)
- Reduced LRRK 2 in association with retromer dysfunction in post-mortem brain tissue from LRRK 2 mutation carriers (2017) (13)
- Very early-onset frontotemporal dementia with no family history predicts underlying fused in sarcoma pathology. (2010) (13)
- P25alpha immunoreactive but alpha-synuclein immunonegative neuronal inclusions in multiple system atrophy. (2006) (12)
- LRP10 in α-synucleinopathies (2018) (12)
- Relative preservation of thalamic centromedian nucleus in parkinsonian patients with dystonia (2009) (12)
- Comparison of the Number of Vasopressin‐Producing Hypothalamic Neurons in Rats and Humans (1995) (12)
- A review of the neuropathology of schizophrenia. (2001) (12)
- Is CHCHD 10 Pro 34 Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis ? (2015) (12)
- Detection of early lymphocyte activation by the fluorescent cell membrane probe N-phenyl-1-naphthylamine. (1979) (12)
- Substance P-like immunoreactive fibres in the ventromedial mesencephalic tegmentum of rat (1988) (11)
- Chronic alcoholism in the absence of Wernicke-Korsakoff syndrome and cirrhosis does not result in the loss of serotonergic neurons from the median raphe nucleus (1996) (11)
- Evaluation of an ELISA system for determination of class-specific antibodies to native and denatured DNA in man. (1985) (11)
- Endogenous progesterone levels and frontotemporal dementia: modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model (2013) (11)
- Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy (2014) (11)
- Electron microscopic analysis of the mesencephalic ventromedial tegmentum in the cat (1984) (11)
- Dementia in long-term Parkinson's disease patients: a multicentre retrospective study. (2020) (11)
- Glucocerebrosidase Activity is Reduced in Cryopreserved Parkinson’s Disease Patient Monocytes and Inversely Correlates with Motor Severity (2021) (11)
- Brain Banking for Research into Neurodegenerative Disorders and Ageing (2019) (11)
- Clarifying the pathological progression of Parkinson’s disease (2008) (11)
- Anatomical and immunohistochemical identification of catecholaminergic neurones in brain slice preparations used in electrophysiology (1996) (11)
- Utilising Molecular Biological and Histopathological Techniques to Study the Dopaminergic System in Patients with Melancholia (1997) (11)
- Clinical and Biological Correlates of White Matter Hyperintensities in Patients With Behavioral-Variant Frontotemporal Dementia and Alzheimer Disease (2021) (11)
- TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia (2016) (10)
- CNS cell type–specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation (2019) (10)
- A Neuroethics Framework for the Australian Brain Initiative (2019) (10)
- The role of transcriptional control in multiple system atrophy (2015) (10)
- The midbrain‐to‐pons ratio distinguishes progressive supranuclear palsy from non‐fluent primary progressive aphasias (2017) (10)
- Quantification of Total and Mutant Huntingtin Protein Levels in Biospecimens Using a Novel alphaLISA Assay (2018) (10)
- Neurofilament-Immunoreactive Neurons Are Not Selectively Vulnerable in Alzheimer's Disease (2001) (10)
- Partial lesion of thalamic ventral intermediate nucleus after chronic high‐frequency stimulation (2004) (10)
- Clinicopathological aspects of motor parkinsonism. (2007) (10)
- Role of hippocalcin in mediating Aβ toxicity. (2012) (9)
- LRRK2 kinase inhibitors reduce alpha-synuclein in human neuronal cell lines with the G2019S mutation (2020) (9)
- Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease Patients (2021) (9)
- Pathology of Parkinson's Disease (2010) (9)
- Analysis of staining methods for different cortical plaques in Alzheimer's disease (1994) (9)
- Interaction between α-synuclein and tau genotypes and the progression of Parkinson's disease. (2011) (9)
- Rhodamine as a fluorescent probe of lymphocyte activation. (1979) (9)
- Insoluble α-synuclein in alzheimer’s disease without lewy body formation (2009) (9)
- Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity (2021) (9)
- GIRK 2 expression in dopamine neurons of the substantia nigra and ventral tegmental area (2014) (9)
- Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer's disease. (2015) (8)
- Increased Expression of the Lysosomal Cholesterol Transporter NPC1 in Alzheimer's Disease (2010) (8)
- The Neural Signature of Impaired Dual‐Tasking in Idiopathic Rapid Eye Movement Sleep Behavior Disorder Patients (2020) (8)
- Tau isoform expression in frontotemporal dementia without tau deposition (2007) (8)
- Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia (2021) (8)
- Reductions in COQ2 Expression Relate to Reduced ATP Levels in Multiple System Atrophy Brain (2019) (8)
- FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration (2010) (8)
- Differences in Sex Distribution Between Genetic and Sporadic Frontotemporal Dementia (2021) (8)
- Mitochondrial ultrastructure and density in a primate model of persistent tardive dyskinesia. (2000) (8)
- Reply: LATE to the PART-y. (2019) (8)
- Insoluble alpha-synuclein in Alzheimer's disease without Lewy body formation. (2005) (8)
- Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes (2021) (8)
- Investigation of the lipid component of neuromelanin (2006) (8)
- Impaired Color Discrimination—A Specific Marker of Hallucinations in Lewy Body Disorders (2019) (8)
- Microwave Modification of the Methenamine Silver Technique for the Demonstration of Alzheimer-Type Pathology (1996) (7)
- Parvalbumin as an anatomical marker for discrete subregions of the ambiguus complex in the rat (1993) (7)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into the complex genetic architecture (2020) (7)
- Intrafamilial Phenotypic Variability in the C9orf72 Gene Expansion: 2 Case Studies (2018) (7)
- Immune responses in the Parkinson's disease brain (2022) (7)
- Regression of melanoma, but not keratoacanthoma, is associated with increased HLA-B22 and decreased HLA-B27 and HLA-DR1. (1999) (7)
- Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages (2022) (7)
- Unilateral rest tremor in vascular parkinsonism associated with a contralateral lesion of the locus coeruleus (2009) (7)
- Alzheimer's amyloid‐β and tau protein accumulation is associated with decreased expression of the LDL receptor‐associated protein in human brain tissue (2020) (7)
- Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosis (2021) (7)
- Von Economo Neurons in Behavioral Variant Frontotemporal Dementia with Underlying Alzheimer's Disease. (2019) (7)
- Effect of L-10B-p-boronophenylalanine-fructose and the boron neutron capture reaction on mouse brain dopaminergic neurons. (1995) (7)
- Antihypertensive medications ameliorate Alzheimer's disease pathology by slowing its propagation (2020) (7)
- Tackling clinical heterogeneity across the amyotrophic lateral sclerosis–frontotemporal dementia spectrum using a transdiagnostic approach (2021) (7)
- An evidence base for noradrenergic deficits in Parkinson's disease (2012) (7)
- Accelerated loss of hypoxia response in zebrafish with familial Alzheimer's disease-like mutation of Presenilin 1. (2020) (7)
- Early white matter pathology in the fornix of the limbic system in Huntington disease (2021) (7)
- Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice (2019) (6)
- Noradrenergic locus coeruleus neurons. (1996) (6)
- Selective Spatiotemporal Vulnerability of Central Nervous System Neurons to Pathologic TAR DNA-Binding Protein 43 in Aged Transgenic Mice. (2018) (6)
- Overview and recent advances in neuropathology. Part 2: Neurodegeneration. (2011) (6)
- Lipid pathway dysfunction is prevalent in patients with Parkinson’s disease (2022) (6)
- Early‐life decline in neurogenesis markers and age‐related changes of TrkB splice variant expression in the human subependymal zone (2017) (6)
- Exploring the Phenotype in Mild Cognitive Impairment to Aid the Prediction of Those at Risk of Transitioning to Parkinson Disease and Dementia With Lewy Bodies (2017) (6)
- Evaluating the Sustained Attention Response Task to Quantify Cognitive Fluctuations in Dementia With Lewy Bodies (2020) (6)
- Hypothalamic symptoms of frontotemporal dementia disorders. (2021) (6)
- Diagnostic evaluation of the substantia nigra (1996) (6)
- Increased aneuploidy is not a universal feature across α‐synucleinopathies (2017) (6)
- Hallucinogenic mechanisms: pathological and pharmacological insights (2014) (6)
- Pathology of dementia with Lewy bodies (2005) (6)
- The role of lysozyme in Alzheimer’s disease (2015) (5)
- Parkinsonism and cerebrovascular disease (2021) (5)
- Author Correction: Parkinson disease-associated cognitive impairment (2021) (5)
- Oligomeric Aβ40 species accumulate in the toxic plaques in Alzheimer's disease (2009) (5)
- The complex relationship between genotype, pathology and phenotype in familial dementia (2020) (5)
- Lesions Associated with the Classic Triad of Parkinsonian Motor Features (2010) (5)
- Early in vivo Effects of the Human Mutant Amyloid-β Protein Precursor (hAβPPSwInd) on the Mouse Olfactory Bulb. (2015) (5)
- Reply: Will FTLD-tau work for all when FTDP-17 retires? (2018) (5)
- Anticipation of onset age in familial Parkinson's disease without SCA gene mutations. (2006) (5)
- Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS‐FTD spectrum (2021) (5)
- The Role of Astrocytes in Parkinson’s Disease (2014) (5)
- Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation (2021) (5)
- Identifying gene expression profiles associated with neurogenesis and inflammation in the human subependymal zone from development through aging (2022) (5)
- Lipid content determines aggregation of neuromelanin granules in vitro. (2007) (5)
- Restricted disease propagation in multiple system atrophy with prolonged survival (2015) (5)
- LATE-NC staging in routine neuropathologic diagnosis: an update (2022) (5)
- Increased VLCFA-lipids and ELOVL4 underlie neurodegeneration in frontotemporal dementia (2021) (5)
- Thalamic vacuolation in acute Wernicke's encephalopathy [corrected]. (1993) (5)
- Thalamic and Cerebellar Regional Involvement across the ALS–FTD Spectrum and the Effect of C9orf72 (2022) (4)
- Ascending Noradrenergic and Serotonergic Systems in the Human Brainstem (1995) (4)
- Globular glial tauopathy with a mutation in MAPT and unusual TDP-43 proteinopathy in a patient with behavioural-variant frontotemporal dementia (2021) (4)
- Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis (2022) (4)
- Clinical Aspects of Alzheimer's Disease. (2017) (4)
- Are mutations in MAPT associated with GGT type III? (2020) (4)
- Progression of Clinical Features in Lewy Body Dementia Can Be Detected Over 6 Months (2021) (4)
- Unlocking the secrets of LRRK2 function with selective kinase inhibitors (2013) (4)
- ESHRD: deconvolution of brain homogenate RNA expression data to identify cell-type-specific alterations in Alzheimer’s disease (2020) (4)
- Pigmentation in the human brain and risk of Parkinson's disease (2010) (4)
- Accelerated loss of hypoxia response in zebrafish with familial Alzheimer’s disease-like mutation of Presenilin 1 (2019) (4)
- Preserved Cognition and Functional Independence after a Large Right Posterior Cerebral Artery Infarct: Longitudinal Clinical and Neuropathological Findings (2006) (4)
- Genetics of Parkinson's Disease (2007) (3)
- Correction to: Chronic traumatic encephalopathy in two former Australian National Rugby League players (2019) (3)
- A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein (2016) (3)
- CORRELATION OF AMYLOID PET EXPRESSED IN CENTILOID UNITS WITH NEUROPATHOLOGICAL FINDINGS IN ALZHEIMER’S DISEASE (2018) (3)
- Neuropathology of three clinical cases prospectively diagnosed as dementia with Lewy bodies (1999) (3)
- Prodromal neuroinvasion of pathological α-synuclein in brainstem reticular nuclei and white matter lesions in a model of α-synucleinopathy (2021) (3)
- Evaluating a novel behavioral paradigm for visual hallucinations in Dementia with Lewy bodies (2021) (3)
- Mechanisms of Disease in FTLD: Gain of Function versus Loss of Function Effects (2014) (3)
- Clarifying Lewy-body parkinsonism with visual hallucinations (2005) (3)
- Genetic risk factors for posterior cortical atrophy (2015) (3)
- Deletion of Alzheimer’s Disease Risk Gene ABCA7 Alters White Adipose Tissue Development and Leptin Levels (2017) (3)
- Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis (2020) (3)
- Common Variants Near ZIC1 and ZIC4 in Autopsy‐Confirmed Multiple System Atrophy (2022) (3)
- MAPT METHYLATION IN ALZHEIMER'S DISEASE (2014) (3)
- DNA extraction from fresh-frozen and formalin-fixed, paraffinembedded human brain tissue (2013) (2)
- Dynamic network impairments underlie cognitive fluctuations in Lewy body dementia (2022) (2)
- Utility of the Addenbrooke’s Cognitive Examination III online calculator to differentiate the primary progressive aphasia variants (2022) (2)
- Apolipoprotein D Upregulation in Alzheimer’s Disease but Not Frontotemporal Dementia (2018) (2)
- The emergence of proto-objects in complex visual hallucinations (2005) (2)
- Factors That Influence Non-Motor Impairment Across the ALS-FTD Spectrum: Impact of Phenotype, Sex, Age, Onset and Disease Stage (2021) (2)
- Examining the presence and nature of delusions in Alzheimer's disease and frontotemporal dementia syndromes (2022) (2)
- An Adaptive Measure of Visuospatial Impairment in Dementia with Lewy Bodies (2022) (2)
- Subject Index Vol. 7, 1996 (1996) (2)
- The differentiation of progressive supranuclear palsy. (2015) (2)
- 1.210 P25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy (2007) (2)
- Lymphocyte stimulation by concanavalin a studied by the fluorescent probe acridine orange (2004) (2)
- Motor deficits associated with changes in β-amyloid in Parkinson's disease (2012) (2)
- Haplotype analysis of the IGF 2-INS-TH gene cluster in Parkinson ’ s disease (2017) (2)
- Immune-inflammatory changes in the substantia nigra in Parkinson's disease (2004) (2)
- Pattern of Midbrain Pathology in Different Parkinsonian Syndromes (1996) (2)
- 001 Altered interval timing as a novel marker of cognitive fluctuations in lewy body dementia (2019) (2)
- Thalmic vaciuation in acute Wernicke's encephalopathy (1993) (2)
- A Neuroethics Framework for the Australian Brain Initiative (2020) (2)
- Limbic thalamus atrophy is associated with visual hallucinations in Lewy body disorders (2022) (2)
- Criteria for Prodromal Parkinson ’ s Disease (2015) (2)
- Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2018) (2)
- Physiologic and Neurotoxic Properties of Aβ Peptides (2007) (2)
- The effect of hydrocortisone on PWM and LPS-induced immunoglobulin production in blood leucocytes from patients with systemic lupus erythematosus. (1983) (2)
- Increased unsaturated lipids underlie lipid peroxidation in synucleinopathy brain (2022) (2)
- Cortical limb myoclonus in pathologically proven progressive supranuclear palsy (2013) (2)
- Early changes in concanavalin A-stimulated lymphocytes detected by the fluorescent probe N-phenyl-1-naphthylamine (2004) (2)
- Prevalence of chronic traumatic encephalopathy in the Sydney Brain Bank (2022) (2)
- Amyotrophic lateral sclerosis features predict TDP-43 pathology in frontotemporal lobar degeneration (2021) (1)
- across RNA cell death gene networks is implicated in the semantic variant of primary progressive aphasia. (2019) (1)
- Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria (2022) (1)
- Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy (2005) (1)
- Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy (2014) (1)
- Reply: Lysosomal dysfunction in Parkinson's disease. (2015) (1)
- Author Correction: Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology (2021) (1)
- The pathogenesis of cingulate atrophy in behavioral variant frontotemporal dementia and Alzheimer’s disease (2013) (1)
- Immune-related genetic enrichment in frontotemporal dementia (2017) (1)
- Regression in melanoma: how relevant is it? (1997) (1)
- Cytoarchitecture and Chemistry of Midbrain Dopaminergic Cell Groups (1995) (1)
- Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease (2020) (1)
- IDENTIFYING THE DYNAMICS OF LEWY BODY FORMATION IN LEWY BODY DISEASES (2014) (1)
- Condensing the Aβ protocol to reduce the effort and cost of NIA-AA guidelines for neuropathologic assessment of Alzheimer disease (2019) (1)
- 2. The relationship between small vessel disease, vascular risk factors and motor and cognitive impairment in Parkinson’s disease: A clinicopathological study (2014) (1)
- Letter to the Editor. (2019) (1)
- Long intervening non-coding RNA 00320 is human brain-specific and highly expressed in the cortical white matter (2015) (1)
- Anterior‐posterior electrophysiological activity characterizes Parkinsonian visual misperceptions (2021) (1)
- P1-217 Beta amyloid toxicity in Alzheimer's disease (2004) (1)
- Disease Primers PARKINSON DISEASE (2017) (1)
- Eating Behaviour and Metabolic Changes across the Spectrum of Motor Neuron Disease and Frontotemporal Dementia. (I12-5E) (2015) (1)
- A Practical Approach to Differentiate the Frontotemporal Tauopathy Subtypes. (2020) (1)
- Unusual α‐synuclein and cerebellar pathologies in a case of hereditary myoclonus‐dystonia without SGCE mutation (2015) (1)
- Familial Alzheimer’s disease in Australia (2020) (1)
- Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease (2021) (1)
- Accelerated loss of hypoxia response and biased allele expression in zebrafish with Alzheimer\'s disease-like mutations (2019) (1)
- Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation (2012) (1)
- Which Basal Ganglia Surgical Targets Ameliorate Parkinsonian Symptoms (2002) (1)
- Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease (2022) (1)
- VISUAL ASSESSMENT OF β-AMYLOID PET SCAN IS IMPROVED BY CAPAIBL (2018) (1)
- Neuroanatomy for the Movement Disorder Specialist (2013) (1)
- Misfolded proteins in Huntington disease fetal grafts: Further evidence of cell‐to‐cell transfer? (2014) (1)
- Subject Index Vol. 17, 2004 (2004) (1)
- Distribution Patterns of Astrocyte Populations in the Human Cortex (2022) (1)
- Native Separation and Metallation Analysis of SOD1 Protein from the Human Central Nervous System: a Methodological Workflow. (2020) (1)
- Neglected cytotoxic T cell invasion of the brain: how specific for Parkinson's disease? (2020) (1)
- Overlap between Central and Peripheral Transcriptomes in Parkinson’s Disease but Not Alzheimer’s Disease (2022) (1)
- Cerebellar integrity and contributions to cognition in C9orf72-mediated frontotemporal dementia (2022) (1)
- The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: A systematic review (2022) (1)
- Parkinson’s progression prediction using machine learning and serum cytokines (2019) (1)
- Single-cell DNA methylation sequencing by combinatorial indexing and enzymatic DNA methylation conversion (2022) (1)
- Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis (2022) (1)
- Narrow doorways alter brain connectivity and step patterns in isolated REM sleep behaviour disorder (2022) (1)
- Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders (2021) (1)
- A small molecule toll-like receptor antagonist rescues α-synuclein fibril pathology (2022) (1)
- Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations (2023) (1)
- Erratum: Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. (Brain (2019) 142, (1503–1527) DOI: 10.1093/brain/awz099) (2019) (1)
- Cytoarchitecture and Chemistry of the Human Ascending Cholinergic System (1995) (0)
- 额颞叶痴呆 (2008) (0)
- Reply to: “Being too inclusive about synuclein inclusions” (2010) (0)
- Contents Vol. 16, 2003 (2003) (0)
- A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse (2011) (0)
- Evaluation ofanELISAsystemfordetermination of class-specific antibodies tonative anddenatured DNA inman (1985) (0)
- VISUAL ASSESSMENT OF β-AMYLOID PET SCAN IS IMPROVED BY CAPAIBL (2018) (0)
- Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies (2020) (0)
- Cross-examining candidate genes implicated in multiple system atrophy (2019) (0)
- Identifying gene expression profiles associated with neurogenesis and inflammation in the human subependymal zone from development through aging (2022) (0)
- 037 Frontotemporal dementia or frontal variant alzheimer’s disease? A case series (2019) (0)
- S2-02-04 The status of a-synuclein in Alzheimer cases with and without Lewy bodies (2006) (0)
- 307: Prevalence of LRRK2 mutations in Australians with Parkinson’s Disease (2007) (0)
- Leucine-rich repeat kinase 2 pathology in aged human brains and neurodegenerative diseases (2006) (0)
- A52 SIRT1 is increased in affected brain regions in huntington disease impacting hypothalamic metabolic pathways (2018) (0)
- Author response: The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability (2020) (0)
- P3.061 Differential distribution of tyrosine hydroxylase isoforms in the human brain (2009) (0)
- OP-BRAI180237 2895..2907 (2018) (0)
- Genome-wide association study identifies the SLC2A14 gene on chromosome 12P13 as a trans-acting locus for methylation of MAPT gene (2015) (0)
- Flow Cytometry Measurement of Glucocerebrosidase Activity in Human Monocytes. (2020) (0)
- Re-submitted to Movement Disorders, 7 May2012 Small-vessel disease in patients with Parkinson Disease: a clinicopathological study (2014) (0)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia (2018) (0)
- Subclass specificity of neuronal IgG in Parkinson's disease (2004) (0)
- Sex-specific lipid dysregulation in the Abca7 knockout mouse brain (2022) (0)
- 643: Promotor polymorphisms lowering parkin expression reduce the age of onset of Parkinson’s disease (2007) (0)
- Progression in Behavioral Variant Frontotemporal Dementia (2015) (0)
- 410: Autosomal dominant late-onset Parkinson’s disease due to a novel A1442P mutation in the LRRK2 gene (2008) (0)
- Transcriptome analysis of grey and white matter cortical tissue in multiple system atrophy (2014) (0)
- Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia (2019) (0)
- O.064 Thalamic changes in Parkinson's disease (2009) (0)
- 78. Genetic influences of sigma-1 receptor and apolipoprotein E on the severity of Alzheimer’s disease (2010) (0)
- Wernicke ' s encephalopathy . chronic alcoholics : identification of Operational criteria for the classification of (2003) (0)
- Astrocytic pathology in parkinsonian syndromes (2009) (0)
- Differences in sex distribution between genetic and sporadic FTD (2021) (0)
- Invited Reply to: “Instrumental Analysis of Gait Abnormalities in Idiopathic Rapid Eye Movement Sleep Behavior Disorder” (2020) (0)
- Brain Banking for Research into Neurodegenerative Disorders and Ageing (2019) (0)
- Chemoselective Bioconjugation of Amyloidogenic Protein Antigens to PEGylated Microspheres Enables Detection of α-Synuclein Autoantibodies in Human Plasma. (2022) (0)
- Mass buildup of soluble oligomeric Aß40 occurs in sporadic Alzheimer's disease (2009) (0)
- Can we clinically diagnose dementia with Lewy bodies yet? (2013) (0)
- Animal modeling an oligodendrogliopathy – multiple system atrophy (2016) (0)
- Investigating the genetic architecture of Dementia with Lewy bodies: a genome-wide association study (2018) (0)
- Identification Of A novel FTD-MND gene on chromosome 16 (2016) (0)
- Evidence for a Null Effect of L-10BPA Neutron Capture Therapy on Mouse Brain Dopamine Tracts (1996) (0)
- Alpha-synuclein biology in Lewy body diseases (2014) (0)
- LETTER TO THE EDITOR Reply: Lysosomal dysfunction in Parkinson’s disease (2015) (0)
- 621: Changes in regional cerebral blood flow relate to cognitive and behavioural symptoms in progressive supranuclear palsy (2007) (0)
- 118. Impact of changes in the consensus diagnostic criteria for dementia with lewy bodies (2009) (0)
- Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways (2015) (0)
- Specificity of inflammatory pathology for Alzheimers disease (2000) (0)
- Epigenetic Evidence That C9orf72 Promoter Hypermethylation Is Protective: A Blinded Replication (P5.168) (2016) (0)
- p25 (cid:1) Relocalizes in Oligodendroglia from Myelin to Cytoplasmic Inclusions in Multiple System Atrophy (2007) (0)
- Multiple system atrophy. (2022) (0)
- P3-294: Post-translational modifications of apolipoprotein-e in the human brain (2008) (0)
- Operational criteria fortheclassification of chronic alcoholics: identification ofWemicke's encephalopathy (1997) (0)
- C59 DIVERSE ETIOLOGIES AND CONVERGENCE OF PATHOLOGY IN ALS (2011) (0)
- Neuropathological diagnostic accuracy of corticobasal degeneration: A review of 140 cases (2015) (0)
- Diffuse Lewybodydisease: clinical features in nine caseswithout coexistent Alzheimer's disease (1996) (0)
- 110 Atrophy of the mediodorsal thalamus is associated with visual hallucinations in lewy body diseases (2018) (0)
- Correction to: Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease (2022) (0)
- Interdisciplinary approaches for the understanding of neuropsychiatric disorders (2002) (0)
- Functional effects of neuromelanin and synthetic melanins in model systems (2005) (0)
- AGED ALZHEIMER’S DISEASE BRAINS EXHIBIT NUMEROUS Aβ BUT ONLY FEW TAU PRIONS (2018) (0)
- Subject Index Vol. 16, 2003 (2003) (0)
- High expression of long intervening non-coding RNA OLMALINC in the human cortical white matter is associated with regulation of oligodendrocyte maturation (2015) (0)
- Plasma Oxytocin Is Not Associated with Social Cognition or Behavior in Frontotemporal Dementia and Alzheimer’s Disease Syndromes (2022) (0)
- P3-260 Non-hyperphosphorylated tau accumulates in the pathological hallmarks in presenilin-1 Alzheimer's disease and frontotemporal dementia (2004) (0)
- Erratum: Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (Scientific reports (2017) 7 1 (8899)) (2018) (0)
- Erratum (1979) (0)
- Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (2020) (0)
- Sunscreens: the way forward. Immune protection factors and protection by oxygen radical scavengers (1997) (0)
- Lesions Associated with Eye Movements (2010) (0)
- 095 Predicting parkinson’s and dementia with lewy bodies (pre-D) research study – a sydney-based longitudinal biobanking program (2019) (0)
- Genome-wide association study of autopsy-confirmed Multiple System Atrophy identifies common variants near ZIC1 and ZIC4 (2021) (0)
- Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis (2017) (0)
- Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity (2021) (0)
- Sigma non-opioid intracellular receptor 1 and neurodegeneration: prevalence of mutations and therapeutic implications (2011) (0)
- Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43 (2013) (0)
- Erratum: A Neuroethics Framework for the Australian Brain Initiative (Neuron (2019) 101(3) (365–369), (S0896627319300054), (10.1016/j.neuron.2019.01.004)) (2020) (0)
- 060 Impaired color discrimination is associated with hallucinations in dementia with lewy bodies (2019) (0)
- S5-03-01 Animal and cellular models - tau-Abeta interaction (2006) (0)
- S9. Autonomic disorders in Parkinson's disease S9.1 Neuropathology in the autonomic system in patients with Parkinson's disease (2009) (0)
- CHAPTER 31 – ORGANIZATION: PYRAMIDAL AND EXTRAPYRAMIDAL SYSTEM (2007) (0)
- ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies (2013) (0)
- Effect of ultra violet radiation on mantoux reactions in humans: 314 (1997) (0)
- 619: Preserved cognition and functional independence after a large right PCA infarct: longitudinal clinical and neuropathological findings (2007) (0)
- P4-087 Familial Alzheimer's disease and cerebral haemorrhage: a second family with the flemish APP ALA692GLY mutation (2004) (0)
- Response from dual perspectives companion (2017) (0)
- Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2017) (0)
- Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia. (2021) (0)
- 093 How to diagnose lewy body dementia? Prevalence and underlying relationship between clinical and neuropsychological features of DLB (2019) (0)
- Thalmic Vaculation in Acute Wernicke's Encephalopathy (0)
- Prevalence of LRRK2 mutations in Australians with Parkinson's disease (2007) (0)
- Thalamic and Cortical Changes in Parkinsonian Disorders (2005) (0)
- Correction to: Prodromal neuroinvasion of pathological α-synuclein in brainstem reticular nuclei and white matter lesions in a model of α-synucleinopathy (2022) (0)
- Progressive supranuclear palsy finally has a clinically measureable τ abnormality (2014) (0)
- NEUROPEPTIDE AND HYPOTHALAMUS CHANGES IN FRONTOTEMPORAL DEMENTIA AND HUNTINGTON'S DISEASE (2010) (0)
- White matter changes in frontotemporal dementia and the C9ORF72 gene expansions (2017) (0)
- 013 Lipid metabolism and body composition in frontotemporal dementia-amyotrophic lateral sclerosis spectrum: effect on survival and disease progression (2018) (0)
- A23 Changes in key hypothalamic neuropeptide populations in Huntington's Disease revealed by neuropathological analyses (2010) (0)
- Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum (2022) (0)
- Contents Vol. 7, 1996 (1996) (0)
- H04 Gene Expression Changes In Emotion And Metabolism Regulating Neuropeptide Systems In The Hypothalamus In Clinical Huntington Disease (2014) (0)
- Global fatty acid composition is altered in Parkinson's disease anterior cingulate cortex (2013) (0)
- Lipid dysfunction and pathogenesis of multiple system atrophy (2014) (0)
- Presence of co‐pathology in sporadic early‐onset Alzheimer disease versus dominantly inherited Alzheimer disease (2021) (0)
- The role of LAMP-2 in AβPP processing and Aβ degradation; implications for Alzheimer’s Disease (2015) (0)
- 1005 Inflammation-related genes affect age at onset of Parkinson's disease (2005) (0)
- LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models (2012) (0)
- 31. Analysis of PINK1 and PARKIN gene mutations in patients with Parkinson’s disease in the Australian community (2009) (0)
- Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2018) (0)
- Evidence of altered TrkB pre-mRNA splicing in Alzheimer's disease (2012) (0)
- Degeneration in different parkinsonian syndromes relates directly to astrocyte type and astrocyte protein expression (2009) (0)
- Title : LRRK 2 Pathology in Sporadic and α-Synuclein A 53 T Mutant Parkinson ’ s Disease (2006) (0)
- 417: A consanguineous family with Frontotemporal Dementia/Motor Neuron Disease (2008) (0)
- Title : LRRK 2 Pathology in Sporadic and α-Synuclein A 53 T Mutant Parkinson ’ s Disease (2006) (0)
- 013 Progression of clinical features in Lewy body dementia can be detected over six months (2021) (0)
- Schizotypal traits across the amyotrophic lateral sclerosis–frontotemporal dementia spectrum: pathomechanistic insights (2022) (0)
- The hummingbird identifies psp among patients with non-fluent primary progressive aphasia (2017) (0)
- SOUTH AUSTRALIA (1917) (0)
- Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease (2018) (0)
- Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages (2022) (0)
- Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis (2022) (0)
- Analysis of Tyrosine Hydroxylase Isoforms and Phosphorylation in Parkinson’s Disease (2014) (0)
- Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting (2023) (0)
- T helper 1 cytokine mRNA is increased in spontaneously regressing primary malignant melanomas: 490 (1997) (0)
- Shorter disease duration in females with sporadic frontotemporal dementia (2022) (0)
- Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability (2019) (0)
- Eating behaviour and metabolism in amyotrophic lateral sclerosis and frontotemporal dementia: providing insights for neurodegeneration (2016) (0)
- Role of Oligodendrocyte Lineage Cells in Multiple System Atrophy (2023) (0)
- Positional cloning identifies SIGMAR1 gene as a causative locus for FTLD-MND in a large Australian pedigree (2011) (0)
- Author response for "Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis" (2021) (0)
- Uncovering pathophysiological changes in frontotemporal dementia using serum lipids (2020) (0)
- Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer’s disease and not in other tauopathies (2019) (0)
- Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia (2023) (0)
- Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease (2021) (0)
- A potential patient stratification biomarker for Parkinso’s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells (2023) (0)
- Transcriptional profiling of multiple system atrophy cerebellar tissue highlights differences between the parkinsonian and cerebellar sub-types of the disease (2020) (0)
- Tau gene mutations are pleiotropic: Identification of two novel mutations in the tau gene (2000) (0)
- MIXED PATHOLOGY IN ALZHEIMER’S DISEASE (2017) (0)
- O2-06-05 CORRELATION OFAMYLOID PET EXPRESSED IN CENTILOID UNITS WITH NEUROPATHOLOGICAL FINDINGS IN ALZHEIMER’S DISEASE (2018) (0)
- Rapid iPSC inclusionopathy models shed light on formation, consequence and molecular subtype of α-synuclein inclusions (2022) (0)
- 3.301 CYTOKINES ASSOCIATED WITH PARKINSON'S DISEASE (2012) (0)
- Inflammatory effects of Aβ alloforms and conformations on human astrocytes (2009) (0)
- Pathway Analysis of the Human Brain Transcriptome in Disease (2012) (0)
- Hierarchical pathological progression of corticobasal degeneration (2017) (0)
- Sleep-related Disturbances in PD Occurring During Daytime Excessive Daytime Sleepiness (2010) (0)
- ε 4 POTENTIATES THE RELATIONSHIP BETWEEN AMYLOID- b AND TAU PATHOLOGIES IN A DOSE- DEPENDENT MANNER (2018) (0)
- Calcium Binding Proteins Differentiate Midbrain Dopaminergic Systems in Humans (1995) (0)
- Title Progression in behavioural variant frontotemporal dementia : a longitudinal study Running Title Progression in frontotemporal dementia (2016) (0)
- ATP-binding cassette transporter expression is widely dysregulated in frontotemporal dementia with TDP-43 inclusions (2022) (0)
- Aging 6-2019 Limbic-Predominant Age-Related TDP-43 Encephalopathy ( LATE ) : Consensus Working Group Report (2019) (0)
- Presenilin-1 familial Alzheimer's disease cases exhibit altered pathology in comparison to sporadic AD (2008) (0)
- Contents Vol. 17, 2004 (2004) (0)
- 622: Visual hallucinations and fluctuating consciousness relate to pathology of the limbic thalamus in Lewy body dementias (2007) (0)
- Explorer Clinicopathological correlates in frontotemporal dementia (2016) (0)
- Lesions Associated with Pain and Sensory Abnormalities (2010) (0)
- Insoluble α-synuclein in the cortex of patients with Alzheimer's disease in the absence of Lewy body information. (2004) (0)
- Early-onset Axonal Pathology in a Novel P301S-Tau Transgenic Mouse Model of Frontotemporal Dementia (2015) (0)
- TrkB pre-mRNA splicing to generate TrkB-Shc transcripts with implications for Alzheimer ' s disease (2016) (0)
- The aging brain and brain banking (2021) (0)
This paper list is powered by the following services:
Other Resources About Glenda Halliday
What Schools Are Affiliated With Glenda Halliday?
Glenda Halliday is affiliated with the following schools:
